FDA
Presence of glass particle prompts Veklury recall

Gilead announced that it's issuing a voluntary recall of one lot of Veklury (remdesivir) 100 mg/vial. The company received a customer complaint and confirmed the presence of a glass particle in the vial during an investigation. To date, Gilead hasn't received any reports of adverse events related to this recall. Tap for more details ...